Literature DB >> 20732303

Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state.

Takashi Matsumoto1, Takayoshi Kinoshita, Yasuyuki Kirii, Koichi Yokota, Kensaku Hamada, Toshiji Tada.   

Abstract

MKK4 activates both JNKs and p38s. We determined the crystal structures of human non-phosphorylated MKK4 kinase domain (npMKK4) complexed with AMP-PNP (npMKK4/AMP) and a ternary complex of npMKK4, AMP-PNP and p38α peptide (npMKK4/AMP/p38). These crystal structures revealed that the p38α peptide-bound npMKK4 at the allosteric site rather than at the putative substrate binding site and induced an auto-inhibition state. While the activation loop of the npMKK4/AMP complex was disordered, in the npMKK4/AMP/p38 complex it configured a long α-helix, which prevented substrate access to the active site and αC-helix movement to the active configuration of MKK4.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732303     DOI: 10.1016/j.bbrc.2010.08.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  MAP kinase modules: the excursion model and the steps that count.

Authors:  Alexander T Piala; John M Humphreys; Elizabeth J Goldsmith
Journal:  Biophys J       Date:  2014-11-04       Impact factor: 4.033

Review 2.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

Review 3.  Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.

Authors:  Christine Yueh; Justin Rettenmaier; Bing Xia; David R Hall; Andrey Alekseenko; Kathryn A Porter; Krister Barkovich; Gyorgy Keseru; Adrian Whitty; James A Wells; Sandor Vajda; Dima Kozakov
Journal:  J Med Chem       Date:  2019-07-05       Impact factor: 7.446

4.  Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.

Authors:  Young-Ho Ahn; Yanan Yang; Don L Gibbons; Chad J Creighton; Fei Yang; Ignacio I Wistuba; Wei Lin; Nishan Thilaganathan; Cristina A Alvarez; Jonathon Roybal; Elizabeth J Goldsmith; Cathy Tournier; Jonathan M Kurie
Journal:  Mol Cell Biol       Date:  2011-09-06       Impact factor: 4.272

Review 5.  Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule.

Authors:  Ashish Kumar Agrahari; Madhu Dikshit; Shailendra Asthana
Journal:  Comput Struct Biotechnol J       Date:  2022-07-11       Impact factor: 6.155

6.  Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma.

Authors:  Ada J Kwong; Thao N D Pham; Hannah E Oelschlager; Hidayatullah G Munshi; Karl A Scheidt
Journal:  ACS Med Chem Lett       Date:  2021-09-15       Impact factor: 4.632

7.  The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold.

Authors:  Sascha Gutmann; Alexandra Hinniger; Gabriele Fendrich; Peter Drückes; Sylvie Antz; Henri Mattes; Henrik Möbitz; Silvio Ofner; Niko Schmiedeberg; Aleksandar Stojanovic; Sebastien Rieffel; André Strauss; Thomas Troxler; Ralf Glatthar; Helmut Sparrer
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

8.  Intrinsic disorder in proteins associated with oxidative stress-induced JNK signaling.

Authors:  Bhuvaneshwari R Gehi; Kundlik Gadhave; Vladimir N Uversky; Rajanish Giri
Journal:  Cell Mol Life Sci       Date:  2022-03-24       Impact factor: 9.261

9.  A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4.

Authors:  Sankar N Krishna; Chi-Hao Luan; Rama K Mishra; Li Xu; Karl A Scheidt; Wayne F Anderson; Raymond C Bergan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome.

Authors:  Zheng Zhao; Lei Xie; Philip E Bourne
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.